Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parissa Farnia

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Mycobacteriology|January 4, 2017
Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiaeParissa Farnia, Donya Malekshahian, Payam Tabarsi, et al.
International Journal of Mycobacteriology|September 15, 2024
Prevalence and Temporal Trends of Multidrug-resistant Tuberculosis in Iran from 1981 to 2023: A Systematic Review and Meta-analysisSaman Ayoubi, Parissa Farnia, Poopak Farnia, et al.
International Journal of Mycobacteriology|June 25, 2024
Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosisSamira Shabani, Poopak Farnia, Jalaledin Ghanavi, et al.
Tuberkuloz Ve Toraks|September 25, 2010
Evaluating the role of vitamin D receptor polymorphisms on susceptibility to tuberculosis among iranian patients: a case-control studySayed Mehran Marashian, Parissa Farnia, Shima Seyf, et al.
The Open Microbiology Journal|March 7, 2014
A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patientsMohammad Varahram, Mohammad Javad Nasiri, Parissa Farnia, et al.
International Journal of Mycobacteriology|December 15, 2015
Nontuberculous mycobacteria in Middle East: Current situation and future challengesAli Akbar Velayati, Sanaz Rahideh, Zahra Derakhshani Nezhad, et al.
Jundishapur Journal of Microbiology|April 1, 2015
Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency VirusMaryam Fatemeh Sheikholeslami, Javid Sadraei, Parissa Farnia, et al.
Archives of Iranian Medicine|March 5, 2020
Prevalence of Mycobacterium abscessus among the Patients with Nontuberculous MycobacteriaSaman Ayoubi, Jafar Aghajani, Poopak Farnia, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 19, 2008
Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from IranFarahnoosh Doustdar, Azar Dokht Khosravi, Parissa Farnia, et al.
Medical Mycology|July 20, 2013
Typing of Pneumocystis jirovecii isolates from Iranian immunosuppressed patients based on the Internal Transcribed Spacer (ITS) region of the rRNA geneMaryam-Fatemeh Sheikholeslami, Javid Sadraei, Parissa Farnia, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Mycobacteriology|January 4, 2017
Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiaeParissa Farnia, Donya Malekshahian, Payam Tabarsi, et al.
International Journal of Mycobacteriology|September 15, 2024
Prevalence and Temporal Trends of Multidrug-resistant Tuberculosis in Iran from 1981 to 2023: A Systematic Review and Meta-analysisSaman Ayoubi, Parissa Farnia, Poopak Farnia, et al.
International Journal of Mycobacteriology|June 25, 2024
Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosisSamira Shabani, Poopak Farnia, Jalaledin Ghanavi, et al.
Tuberkuloz Ve Toraks|September 25, 2010
Evaluating the role of vitamin D receptor polymorphisms on susceptibility to tuberculosis among iranian patients: a case-control studySayed Mehran Marashian, Parissa Farnia, Shima Seyf, et al.
The Open Microbiology Journal|March 7, 2014
A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patientsMohammad Varahram, Mohammad Javad Nasiri, Parissa Farnia, et al.
International Journal of Mycobacteriology|December 15, 2015
Nontuberculous mycobacteria in Middle East: Current situation and future challengesAli Akbar Velayati, Sanaz Rahideh, Zahra Derakhshani Nezhad, et al.
Jundishapur Journal of Microbiology|April 1, 2015
Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency VirusMaryam Fatemeh Sheikholeslami, Javid Sadraei, Parissa Farnia, et al.
Archives of Iranian Medicine|March 5, 2020
Prevalence of Mycobacterium abscessus among the Patients with Nontuberculous MycobacteriaSaman Ayoubi, Jafar Aghajani, Poopak Farnia, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 19, 2008
Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from IranFarahnoosh Doustdar, Azar Dokht Khosravi, Parissa Farnia, et al.
Medical Mycology|July 20, 2013
Typing of Pneumocystis jirovecii isolates from Iranian immunosuppressed patients based on the Internal Transcribed Spacer (ITS) region of the rRNA geneMaryam-Fatemeh Sheikholeslami, Javid Sadraei, Parissa Farnia, et al.
Pageof 11